{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:47:20Z","timestamp":1781668040156,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.bone.2019.115137","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T02:33:09Z","timestamp":1574130789000},"page":"115137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Iron replacement ameliorates hypophosphatemia in autosomal dominant hypophosphatemic rickets: A review of the role of iron"],"prefix":"10.1016","volume":"131","author":[{"given":"Lakshmi P.","family":"Menon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bone.2019.115137_bb0005","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23","volume":"26","author":"ADHR Consortium","year":"2000","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.bone.2019.115137_bb0010","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1210\/jcem.82.2.3765","article-title":"Autosomal dominant hypophosphatemic rickets\/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder","volume":"82","author":"Econs","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.bone.2019.115137_bb0015","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1074\/jbc.M210490200","article-title":"The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency","volume":"278","author":"Bai","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bone.2019.115137_bb0020","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2443.2005.00853.x","article-title":"Fibroblast growth factor 23 reduces expression of type IIa Na+\/Pi co-transporter by signaling through a receptor functionally distinct from the known FGFRs in opossum kidney cells","volume":"10","author":"Yan","year":"2005","journal-title":"Genes Cells"},{"issue":"5","key":"10.1016\/j.bone.2019.115137_bb0025","doi-asserted-by":"crossref","first-page":"F1577","DOI":"10.1152\/ajprenal.00463.2006","article-title":"Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro","volume":"293","author":"Perwad","year":"2007","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"3","key":"10.1016\/j.bone.2019.115137_bb0030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.bone.2019.115137_bb0035","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1210\/jc.2011-1239","article-title":"Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans","volume":"96","author":"Imel","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2019.115137_bb0040","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/bbrc.2000.3696","article-title":"Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain","volume":"277","author":"Yamashita","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.bone.2019.115137_bb0045","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1681\/ASN.2007010068","article-title":"How fibroblast growth factor 23 works","volume":"18","author":"Liu","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.bone.2019.115137_bb0050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bone.2004.04.002","article-title":"FGF23 is processed by proprotein convertases but not by PHEX","volume":"35","author":"Benet-Pag\u00e8s","year":"2004","journal-title":"Bone."},{"issue":"1","key":"10.1016\/j.bone.2019.115137_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-07-0095","article-title":"The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis","volume":"194","author":"Razzaque","year":"2007","journal-title":"J. Endocrinol."},{"issue":"9","key":"10.1016\/j.bone.2019.115137_bb0060","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1128\/MCB.02249-06","article-title":"Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members","volume":"27","author":"Goetz","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bone.2019.115137_bb0065","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M112.342980","article-title":"Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor","author":"Goetz","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bone.2019.115137_bb0070","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/endo.143.8.8795","article-title":"Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo","volume":"143","author":"Shimada","year":"2002","journal-title":"Endocrinology."},{"issue":"1","key":"10.1016\/j.bone.2019.115137_bb0075","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.0902006107","article-title":"Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation","volume":"107","author":"Goetz","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.bone.2019.115137_bb0080","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2169\/internalmedicine.47.0730","article-title":"Physiological regulation and disorders of phosphate metabolism\u2014pivotal role of fibroblast growth factor 23","volume":"47","author":"Fukumoto","year":"2008","journal-title":"Intern. Med."},{"issue":"9","key":"10.1016\/j.bone.2019.115137_bb0090","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/jbmr.433","article-title":"FGF-23\/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH","volume":"26","author":"Yuan","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.bone.2019.115137_bb0095","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1210\/jc.2004-0724","article-title":"FGF-23 is elevated by chronic hyperphosphatemia","volume":"89","author":"Gupta","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2019.115137_bb0100","article-title":"Fibroblast growth factor (FGF)-23 in patients with hypoparathyroidism","volume":"15","author":"Yamashita","year":"2005","journal-title":"Clin Calcium."},{"issue":"6","key":"10.1016\/j.bone.2019.115137_bb0105","doi-asserted-by":"crossref","first-page":"e1613","DOI":"10.1542\/peds.2010-1365","article-title":"Elevated fibroblast growth factor 23 levels in a newborn with secondary hypoparathyroidism","volume":"126","author":"Bech","year":"2010","journal-title":"Pediatrics."},{"issue":"11","key":"10.1016\/j.bone.2019.115137_bb0110","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1210\/jc.2013-2705","article-title":"Deliberate total parathyroidectomy: a potentially novel therapy for tumor-induced hypophosphatemic osteomalacia","volume":"98","author":"Bhadada","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.bone.2019.115137_bb0115","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"8","key":"10.1016\/j.bone.2019.115137_bb0120","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/jbmr.1923","article-title":"Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women","volume":"28","author":"Wolf","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"Pt 2","key":"10.1016\/j.bone.2019.115137_bb0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1258\/acb.2008.008151","article-title":"Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia","volume":"46","author":"Schouten","year":"2009","journal-title":"Ann. Clin. Biochem."},{"issue":"7","key":"10.1016\/j.bone.2019.115137_bb0130","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1210\/jc.2008-2396","article-title":"FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study","volume":"94","author":"Schouten","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bone.2019.115137_bb0135","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.bone.2009.06.017","article-title":"Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia","volume":"45","author":"Shimizu","year":"2009","journal-title":"Bone."},{"issue":"12","key":"10.1016\/j.bone.2019.115137_bb0140","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1210\/jc.2017-01211","article-title":"Sex and iron modify fibroblast growth factor 23 concentration in 1-year-old children","volume":"102","author":"Holmlund-Suila","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.bone.2019.115137_bb0145","first-page":"1514","article-title":"Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets","volume":"75","author":"Rivkees","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bone.2019.115137_bb0150","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1074\/jbc.M408903200","article-title":"Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo","volume":"280","author":"Saito","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bone.2019.115137_bb0155","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1210\/jc.2015-2391","article-title":"Iron supplementation associated with loss of phenotype in autosomal dominant hypophosphatemic rickets","volume":"100","author":"Kapelari","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2019.115137_bb0160","doi-asserted-by":"crossref","first-page":"F249","DOI":"10.1152\/ajprenal.00542.2015","article-title":"Klotho\/fibroblast growth factor 23- and PTH-independent estrogen receptor-\u03b1-mediated direct downregulation of NaPi-IIa by estrogen in the mouse kidney","volume":"311","author":"Webster","year":"2016","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"4","key":"10.1016\/j.bone.2019.115137_bb0165","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1210\/jc.2016-4038","article-title":"FGF23 is not associated with age-related changes in phosphate, but enhances renal calcium reabsorption in girls","volume":"102","author":"Mitchell","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219304314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219304314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:47:29Z","timestamp":1757612849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328219304314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":32,"alternative-id":["S8756328219304314"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2019.115137","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron replacement ameliorates hypophosphatemia in autosomal dominant hypophosphatemic rickets: A review of the role of iron","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2019.115137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115137"}}